Study of FeNO as a marker for immunotherapy response in lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This trial is testing whether a simple breath test (FeNO) can predict how well immunotherapy works in people with advanced lung cancer who haven't had treatment before. It's for patients whose tumors have high PD-L1 levels and who will receive immunotherapy alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have advanced non-small cell lung cancer that has spread (metastatic)
- You have not had any previous treatment for your lung cancer
- Your tumor has high PD-L1 levels (more than 50%)
- You are 18 years or older
- You speak and read French
- You can perform a simple breath test (blowing into a device)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks whether tiny bits of tumor DNA in the blood can be measured over time in people with non-small cell lung cancer who are receiving immunotherapy. It aims to see if these blood tests can help track the cancer response or changes during treatment.
This trial is for people with stage IIA to IIIB non-small cell lung cancer that can be removed by surgery. It tests if certain white blood cells (neutrophils) can help predict how well chemotherapy combined with immunotherapy works before surgery.
This study tests a new device that measures a lung marker called FeNO (fractional exhaled nitric oxide) to help diagnose asthma. It may be an option for adults with asthma who have not changed their medication recently and have no recent infections.
This study measures a lung inflammation marker called FeNO in ICU patients on a breathing machine. It may help doctors understand lung health and guide treatment.
This study looks at a specific kind of inflammation (called Type 2) in people with asthma. Researchers want to see how common it is and how it affects asthma symptoms.
This trial is testing whether a simple breath test called FeNO can help doctors diagnose asthma more accurately. It's for people who have symptoms that might be asthma, but haven't been diagnosed yet.
Hear when a new Metastatic Non-small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.